Yong-Soo Bae | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Yong-Soo Bae | Immunology Cellular Interactions | Best Researcher Award

Prof. Dr. Yong-Soo Bae | Sungkyunkwan University | South Korea

Dr. Yong-Soo Bae is a distinguished immunologist and professor at the Department of Biological Science, Sungkyunkwan University, Korea. He currently serves as the Director of the SRC Center for Immune Research on Non-lymphoid Organs (CIRNOS). With over three decades of academic, clinical, and industry experience, Dr. Bae is internationally recognized for his pioneering research in immunology, virology, and vaccine development. His multidisciplinary contributions span academia, biotech innovation (as CEO/CTO of JW Creagene Inc.), and scientific leadership, including organizing global conferences and serving as editor-in-chief and president in numerous societies. His work focuses on immune modulation, cancer immunotherapy, and mucosal vaccines, which has led to influential publications in prestigious journals like Nature Communications, Science Advances, and Advanced Materials. Dr. Bae’s career reflects a commitment to innovation, collaboration, and education, making him a strong candidate for the Best Researcher Award.

Publication Profile:

Scopus

✅ Strengths for the Award

  1. Pioneering Research Leadership
    Dr. Bae has led groundbreaking research in immunology, particularly in immune regulation of non-lymphoid organs, vaccine development, and cancer immunotherapy. His leadership of the Center for Immune Research on Non-lymphoid Organs (CIRNOS) demonstrates his national influence in immune research.

  2. Extensive Scientific Contributions
    With over 18 high-impact publications in the past 3–4 years alone, including in top-tier journals like Nature Communications, Molecular Therapy, Science Advances, and Advanced Materials, Dr. Bae continues to push the boundaries of translational immunology and personalized medicine.

  3. International & Interdisciplinary Experience
    His training at Harvard Medical School, his professorships across Korean institutions, and leadership at JW Creagene Inc. showcase both academic and industrial impact.

  4. Scientific Community Engagement
    Roles such as Editor-in-Chief, society president, and organizer of global conferences (e.g., DC2012) reflect his commitment to advancing scientific dialogue and collaboration.

  5. Mentorship and Institutional Development
    Dr. Bae has contributed significantly to capacity building in Korea’s biomedical research landscape, mentoring junior scientists and shaping departmental growth.

⚠️ Areas for Improvement:

  1. Global Collaboration Visibility
    While his work is highly impactful in Korea and Asia, more joint publications with global institutions (e.g., NIH, Oxford, Karolinska) could further enhance international research influence.

  2. Patent and Commercial Output Reporting
    As former CEO/CTO of JW Creagene, elaborating on patented innovations or therapeutic products brought to market would strengthen the case for translational impact.

  3. Formal Recognition or Awards
    Inclusion of formal honors (e.g., national science medals, international society awards) would help quantify his recognition outside Korea.

  4. Consistent Author Disambiguation
    In some publications, author names appear as “Y.S. Bae” or “Yong-soo Bae.” Consistent use of a standardized author name across indexing platforms would help centralize his citation metrics and scholarly footprint.

 

🎓 Education:

Dr. Yong-Soo Bae’s academic journey began with a Bachelor’s and Master’s degree in Microbiology from Seoul National University in 1981 and 1983, respectively. His foundational training in microbiology laid the groundwork for his research trajectory in infectious disease and immunology. He earned his Ph.D. in 1990 from the University of Calgary, Alberta, Canada, in the Virology Division of the Department of Microbiology and Infectious Diseases, Faculty of Medicine. His doctoral research was crucial in shaping his interest in host-pathogen interactions and immune regulation. Dr. Bae’s international education experience has enabled him to blend Western and Eastern biomedical research paradigms, contributing to his ability to lead collaborative global projects and initiatives in immunotherapy and vaccine innovation.

💼 Experience:

Dr. Yong-Soo Bae’s professional career spans academia, research, and biotech leadership. He completed a postdoctoral fellowship at Dana-Farber Cancer Institute, Harvard Medical School (1991–1993), which enriched his expertise in cancer immunology. He held professorial roles at Hannam University (1993–2003) before joining Sungkyunkwan University in 2004, where he later became Department Chair and Distinguished Professor. Dr. Bae also served as Director of CIRNOS (2017–2024) and led JW Creagene Inc. as CEO/CTO (1998–2015), bridging science and industry. His editorial and leadership roles include Editor-in-Chief of the Journal of Bacteriology and Virology, President of the Korean Society of Virology, and Vice President of the Korean Vaccine Society. His diverse roles demonstrate a unique blend of academic excellence, organizational leadership, and translational research expertise.

🔍 Research Focus:

Dr. Yong-Soo Bae’s research focuses on innate and adaptive immune regulation, tumor immunology, mucosal immunotherapy, and vaccine delivery. He investigates cellular interactions in the immune microenvironment, with particular attention to innate lymphoid cells (ILCs), neutrophils, and dendritic cells. His translational work includes novel vaccine platforms, epitranscriptomics, immune checkpoint modulation (e.g., CISH, PD-1), and cell therapy for diseases such as asthma, leukemia, and cancer. He also explores microbiome-immune crosstalk and inflammation-related organ damage (e.g., renal fibrosis, lung inflammation). His group has published extensively on m6A modifiers, microRNAs, and innovative delivery systems like gel-to-nanovaccines. His latest studies dive into immunometabolism and the interplay between immune cells and tissue repair, offering groundbreaking insights for future immunotherapies. Dr. Bae’s work is highly cited and remains at the forefront of immune system-based therapeutic innovation.

📚 Publications Top Notes:

  1. 📘 Therapeutic Potential of microRNA Against Th2-associated Immune Disorders – Current Topics in Medicinal Chemistry (2021)

  2. 💉 COVID-19 Vaccines and Oral-Mucosal Vector System as a Potential Vaccine Platform – Vaccines (2021)

  3. 🧬 Immunotherapeutic Potential of m6A-Modifiers and microRNAs in AML – Biomedicines (2021)

  4. 🎯 Epitranscriptomic Approach to Improve ICB Therapy by Targeting CISH – Cells (2021)

  5. 🧫 TFH-B-TRM Dysregulation and Anti-PD-1 Responses in EGFR-mutant Lung Cancer – Nature Communications (2021)

  6. 🧪 Adenoviral CD200R-Ig Enhances Antitumor Immunity via M2 Macrophage Inhibition – Molecular Therapy

  7. 🌫 Air Pollutant-induced Neutrophils Worsen Airway Inflammation – JACI (2021)

  8. 🦠 NCR+ILC3s and the Microbiome in Asthma Severity – Immune Network (2021)

  9. 📖 Advances in Personalized Therapy for AML by Targeting Intracellular Checkpoints – eBook Chapter (2021)

  10. 🧵 Siglec-F Neutrophils Drive Fibrosis in Renal Disease – JCI (2022)

🧾 Conclusion:

Dr. Yong-Soo Bae is an exceptional and highly deserving candidate for the Best Researcher Award. His contributions over four decades span foundational research, translational innovation, academic leadership, and scientific diplomacy. The depth of his scientific output, particularly in immunology, epigenetics, and vaccine development, is matched by his long-term commitment to mentoring, editorial work, and building research institutions in Korea.While enhancing his global recognition and expanding international collaborative outputs could further elevate his status, Dr. Bae’s consistent high-impact contributions, research leadership, and policy involvement clearly position him as a top-tier researcher in the life sciences.

Miriam Götte | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Miriam Götte | Immunology Cellular Interactions | Best Researcher Award

Assist. Prof. Dr. Miriam Götte , Westdeutsches Tumorzentrum, Universitätsklinikum Essen , Germany

Dr. Miriam Götte is a leading expert in exercise and movement science in oncology, currently affiliated with the University Hospital Essen. With a dedicated focus on pediatric and young adult cancer care, she has led numerous interdisciplinary initiatives combining sports science, immunology, and oncology. As head of the Working Group on Sports and Movement Therapy at the West German Tumor Center, she has pioneered therapeutic interventions improving the quality of life in cancer patients. Dr. Götte holds a habilitation in Movement Science in Oncology and has been a postdoctoral researcher since 2014. Her work has been recognized nationally and internationally through prestigious awards. Passionate about improving survivorship care, she integrates clinical research, physical rehabilitation, and academic leadership. Alongside her academic career, she balances motherhood, having taken two parental leaves, which reflects her ability to manage demanding roles in both personal and professional spheres.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. 🌍 Leading Expertise in Exercise Oncology: Dr. Götte has made outstanding contributions to the field of exercise-based interventions in pediatric and adolescent oncology, a highly impactful and emerging research domain.

  2. 📊 Rich and Relevant Research Output: With over 10 peer-reviewed publications in top-tier journals (2023–2024 alone), she is actively contributing novel data, especially around HIIT, immune response, stem cell transplantation, and survivorship care.

  3. 👩‍🔬 Translational Focus with Real-World Impact: Her work bridges clinical research and applied therapy, ensuring that findings benefit patient quality of life and recovery during and after cancer treatment.

  4. 🤝 National Leadership and Collaborations: As Head of the Working Group on Sports and Movement Therapy and a core member of the ActiveOncoKids Network, she leads national initiatives and cross-border collaborations.

  5. 🏆 Recognized with Prestigious Awards: Awards such as the MASCC Young Investigator Award (2015) and Best Abstract at ASORS (2017) reflect her high academic standing and the relevance of her research.

  6. 📚 Interdisciplinary Approach: Combining sports science, immunology, pediatrics, and education, she exemplifies a multidisciplinary perspective that advances both research and therapeutic care.

⚙️ Areas for Improvement:

  1. 📣 Global Visibility: While well-known in German-speaking countries and European forums, increasing participation in global oncology or exercise medicine symposia (e.g., ASCO, ACSM) would raise international recognition.

  2. 💼 Expanded Mentorship: Publishing with more junior researchers as first authors could further support the next generation and solidify her legacy as a mentor in her field.

  3. 🌐 Broader Public Engagement: Developing online modules, webinars, or patient-facing tools (especially for young survivors) could enhance public awareness and dissemination of her impactful work.

🎓 Education:

Dr. Miriam Götte has a solid academic background in sports and medical sciences. She began her academic journey studying Sports Science with a focus on prevention and rehabilitation at the University of Cologne from 2006 to 2010. During this period, she also pursued studies in Educational Sciences. She advanced to a doctoral program in Medical Sciences at the University of Duisburg-Essen, completing it between 2010 and 2014 under the mentorship of Prof. Dr. Dirk Reinhardt. Her academic accomplishments culminated in a habilitation in “Movement Science in Oncology” at the Medical Faculty of the University of Duisburg-Essen in 2022. This advanced qualification marks her as an expert in the interplay of exercise and oncology, particularly for pediatric and adolescent populations. Her academic path has been underpinned by a strong interdisciplinary approach, combining sports science, oncology, and education to support patients holistically.

💼 Experience:

Dr. Götte’s professional journey began at the Department of Pediatrics III, University Hospital Essen, where she worked from 2010 to 2014 during her doctoral training. She later became head of Sports and Exercise Therapy at the West German Tumor Center (2014–2017) and continued in leadership roles at the same institution until July 2023. Since January 2023, she has served as head of the Working Group on Sports and Movement Therapy in Oncology, playing a pivotal role in the ActiveOncoKids Center Ruhr. Dr. Götte also coordinated teacher training modules in Spanish and led national collaborations to develop exercise strategies during cancer treatment. She has taken two parental leaves (2017–2018 and 2023–2024), highlighting her balance between research and personal life. Her hands-on leadership in multi-center projects and her dedication to integrating physical activity into oncology care make her a driving force in supportive cancer therapy.

🏆 Awards and Honors:

Dr. Miriam Götte has received numerous awards recognizing her impactful research and leadership. She was honored with the Young Investigator Award of the Year at the MASCC/ISOO Annual Meeting on Supportive Care in Cancer in 2015. Her work on adolescent cancer care earned the Best Abstract Award at the 5th ASORS Congress in 2017. She was selected for the prestigious Josepha and Charlotte von Siebold Habilitation Support Program (2018–2019), and later received support from the Corona Care in Medicine Program (2020–2021) by the Medical Faculty of the University of Duisburg-Essen. These accolades underline her academic excellence and leadership in movement science and oncology. Dr. Götte’s pioneering research continues to shape exercise-based cancer therapy, especially for children and adolescents, earning her national and international recognition as a forward-thinking clinician-scientist.

🔬 Research Focus:

Dr. Miriam Götte’s research revolves around exercise oncology, with a strong emphasis on pediatric and adolescent cancer patients. Her primary interest lies in exploring how physical activity interventions, particularly high-intensity interval training (HIIT), influence immune function, physical fitness, and quality of life during and after cancer therapy. She investigates the physiological and psychological impacts of exercise throughout different treatment phases, including stem cell transplantation. Her work contributes significantly to the emerging field of supportive oncology, where movement-based interventions are tailored to patient needs. Dr. Götte is also a central figure in the ActiveOncoKids network, enhancing access to structured physical activity across German-speaking countries. With a translational approach, her research bridges clinical care, immunological assessments, and rehabilitative exercise programs. Her focus is not only scientific but also deeply patient-centered, advocating for movement as a form of healing and empowerment in cancer survivorship.

📚 Publications Top Notes:

  1. 🏋️‍♂️ High-Intensity Interval Training Boosts Immune Cells in Advanced Cancer Patients and Healthy Controls – Cancer Medicine (submitted)

  2. 🧬 Impact of a Single HIIT Session on NK Cells and ILCs in Adolescents Undergoing Cancer Treatment – BMC Cancer (minor revision)

  3. 🌟 YOUEX: Longitudinal Effects on Quality of Life in Young Adults with Cancer – JAYAO (submitted)

  4. 💪 Low vs. Moderate Intensity Exercise in Pediatric Allo-HSCT Recovery – ANIMAL – Pediatric Blood & Cancer (submitted)

  5. 👶 Physical Activity Behaviors in Childhood Cancer Survivors – J Cancer Survivorship (2024)

  6. 🧒 ActiveOncoKids: Centralized Physical Activity Counseling During Oncology – Klinische Pädiatrie (2024)

  7. 🏃 Severely Reduced Physical Performance at Stem Cell Transplant Admission – BMJ Open Sport Exerc Med (2024)

  8. 🧘 P-move: RCT of Exercise in Pancreatic or Biliary Tract Cancer – Supportive Care in Cancer (2024)

  9. 🌿 Exercise Therapy in Oncology: Impact on Quality of Life and Side Effects – Dtsch Arztebl Int (2024)

  10. 🧑‍⚕️ Adaptation of Pediatric Exercise Programs During COVID-19 in Germany – Frontiers in Pediatrics (2024)

🧾 Conclusion:

Dr. Miriam Götte is highly suitable and deserving of the Best Researcher Award. Her focused and prolific research on the role of physical activity in pediatric and adolescent oncology, combined with her leadership in clinical and academic settings, sets her apart as a pioneer in supportive cancer care. She demonstrates a rare combination of scientific rigor, patient-centeredness, and organizational leadership. With strategic expansion of her international visibility and mentoring activities, she is positioned to become one of the global leaders in exercise oncology.

Dia Aldeen Alfaki | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Mr. Dia Aldeen Alfaki | Immunology Cellular Interactions | Best Researcher Award

Mr. Dia Aldeen Alfaki , Alzaiem Alazhari University , Sudan

Dia Alfaki is a Sudanese biomedical scientist with a Master of Biomedical Sciences and extensive experience in haematology, molecular biology, and immunology. His research focuses on the complexities of disease mechanisms and therapeutic solutions, particularly within immunology. As a junior researcher and PG Member of the British Society of Immunology, Dia has contributed significantly to studies on malaria and immune responses. His academic background includes a Master’s degree from Alzaiem Alazhari University and a Bachelor’s degree from Omdurman Islamic University. Dia’s dedication to understanding disease complexities through research is reflected in his growing academic presence and expertise in clinical laboratory techniques. He is committed to advancing scientific knowledge and improving healthcare solutions through his research endeavors.

Publication Profile: 

Orcid

Strengths for the Award:

Dia Alfaki has a remarkable blend of educational qualifications, practical experience, and academic research, making him highly suitable for the Research for Best Researcher Award. His work spans critical areas in biomedical sciences, with a special focus on immunology, haematology, and molecular biology, especially in relation to infectious diseases like malaria. His Master’s research on immune responses to Plasmodium falciparum infection stands out, demonstrating his ability to identify novel immunological markers. His published work in well-regarded journals like Microbiologia Medica and Immunology & Cell Biology further showcases his expertise. He has actively contributed to the scientific community through various international conferences, highlighting his commitment to advancing research. His work at G42 Healthcare underscores his technical skills in molecular diagnostics and cutting-edge biomedical research. His collaborative nature, critical thinking, and proven leadership in research make him a strong contender for this award.

Areas for Improvement:

While Dia Alfaki has a solid foundation in immunology and biomedical research, further expansion of his research portfolio into diverse therapeutic fields could enhance his profile. Gaining more experience in clinical settings beyond molecular labs could provide him with a broader perspective in healthcare applications. Additionally, his involvement in multi-disciplinary research collaborations across diverse disease areas such as oncology and genomics would elevate his impact on global biomedical challenges. Developing greater expertise in bioinformatics tools and integrating them into his molecular research would further refine his analytical skills and position him as an even more influential scientist in his field.

Education:

Dia Alfaki holds a Master’s degree in Biomedical Sciences from Alzaiem Alazhari University (2014-2016), where he specialized in Medical Laboratory Sciences with a focus on Haematology and Blood Transfusion, achieving a CGPA of 3.19/4.0. He completed his Bachelor’s degree in Medical Laboratory Sciences from Omdurman Islamic University (2007-2011), where he excelled in Hematology and Immunohematology. Additionally, Dia is pursuing certification as an International Medical Lab Technologist in Hematology (ASCPi) from the American Society for Clinical Pathology (2022-2025). His academic and professional development demonstrates a strong foundation in biomedical sciences, preparing him to make significant contributions to immunology research and clinical diagnostics.

Experience:

Dia Alfaki has worked as a Molecular Lab Technologist at G42 Healthcare (Biogenix Molecular Labs) from 2020-2023, contributing to advanced molecular research and diagnostics. His expertise spans a wide range of laboratory techniques, particularly in immunology, molecular biology, and hematology. Throughout his career, Dia has been involved in various research projects, including his Master’s thesis focused on the immune response to Plasmodium falciparum infection. He has also contributed to several high-impact publications, collaborating with experts in the field of malaria, immune phagocytosis, and cancer immunology. His role in molecular diagnostics has allowed him to apply his research findings to real-world clinical settings, furthering the understanding of disease pathology and therapeutic interventions.

Awards and Honors:

Dia Alfaki has been recognized for his significant contributions to biomedical science, particularly in immunology research. He participated in prominent international conferences, including the 6th European Congress of Immunology (2022) and the American Association for Cancer Research Annual Meeting (2021). His ongoing work in malaria immunology and cancer immunology is highly regarded in scientific communities. As a PG Member of the British Society of Immunology since 2021, Dia continues to gain recognition for his research on immune responses and inflammation. His work has also been highlighted in various prestigious journals, where his research on malaria and immune responses has earned accolades. These honors reflect his commitment to advancing scientific knowledge and improving healthcare through rigorous research.

Research Focus:

Dia Alfaki’s research is primarily focused on immunity, inflammation, cancer immunology, and molecular oncology. His work emphasizes understanding disease mechanisms, particularly the immune responses involved in infections like malaria and the pathogenesis of diseases such as cancer. Dia is particularly interested in the role of immune mediators, phagocytosis, and molecular interactions in disease progression and therapy. His research aims to explore therapeutic perspectives in immunology, using molecular and cellular approaches to better understand disease complexities and improve treatment options. His publications highlight these areas, especially in the context of malaria and inflammatory immune responses. Dia is also committed to utilizing molecular techniques and bioinformatics tools to contribute to new therapeutic strategies for immunological diseases.

Publications Top Notes:

  1. Patterns of Mannose-Binding Lectin (MBL) responses to Plasmodium falciparum infections in hyperendemic settings 📚🔬
  2. Inflammatory immune mediators and Plasmodium falciparum infection: a cross-sectional study among Sudanese patients with severe and uncomplicated malaria 🌍🦠
  3. Monocytes to lymphocytes ratio in peripheral blood and immunoglobulin IgE levels as indicators to Plasmodium falciparum infection in Sudan 📖🔬
  4. The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy 🦠🔬
  5. Plasmodium falciparum and immune phagocytosis: characterization of the process 🦠💉

Conclusion:

Dia Alfaki is an outstanding researcher with a well-rounded background in biomedical sciences, molecular biology, and immunology. His research accomplishments, publications, and contributions to international conferences highlight his drive for advancing scientific knowledge, particularly in the area of disease mechanisms and immune responses. His strong academic foundation, coupled with his practical lab experience and active engagement with the scientific community, positions him as an excellent candidate for the Research for Best Researcher Award. With a few areas of growth in clinical practice and cross-disciplinary collaborations, he has the potential to become a leader in global biomedical research.